PAVmed Inc. — Director's Dealing 2018

Feb 16, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2018-02-14

Reporting Person: Aklog Lishan (Director, Chairman and CEO, 10% Owner)
Reporting Person: HCFP/Capital Partners III LLC (10% Owner)
Reporting Person: Pavilion Venture Partners LLC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-02	Common Stock	G	34153	—	Disposed	588413	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-14	Employee Stock Option (Right to Buy)	$2.01	A	195108	Acquired	2028-02-14	Common Stock (195108)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1285	Indirect
Common Stock	1300	Indirect
Common Stock	4456570	Indirect
Common Stock	20000	Indirect

Footnotes

F1: The reporting person transferred these shares of common stock by bona fide gift to a third party.

F2: Dr. Aklog is a member and sole manager of Pavilion Venture Partners LLC, and has sole voting and dispositive power over the shares held by this entity. Dr. Aklog disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein.

F3: Dr. Aklog is a co-manager of HCFP/AG LLC, and shares joint voting and dispositive power over the shares held by this entity. Dr. Aklog disclaims beneficial ownership of shares held by this entity, except to the extent of his pecuniary interest therein.

F4: The option vests in 12 equal quarterly installments commencing on March 31, 2018.